Chemoinformaics analysis of Tetracosyl acetate
| Molecular Weight | 396.7 | nRot | 23 |
| Heavy Atom Molecular Weight | 344.284 | nRig | 16 |
| Exact Molecular Weight | 396.397 | nRing | 0 |
| Solubility: LogS | -2.421 | nHRing | 0 |
| Solubility: LogP | 2.773 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 79.6972 |
| nHD | 0 | BPOL | 54.7708 |
| QED | 0.906 |
| Synth | 3.429 |
| Natural Product Likeliness | 1.279 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.502 |
| Pgp-sub | 0.968 |
| HIA | 0.004 |
| CACO-2 | -4.541 |
| MDCK | 0.0000169 |
| BBB | 0.813 |
| PPB | 0.635417 |
| VDSS | 2.248 |
| FU | 0.209233 |
| CYP1A2-inh | 0.057 |
| CYP1A2-sub | 0.931 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.303 |
| CYP2d6-inh | 0.792 |
| CYP2d6-sub | 0.914 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.904 |
| CL | 10.609 |
| T12 | 0.684 |
| hERG | 0.206 |
| Ames | 0.025 |
| ROA | 0.048 |
| SkinSen | 0.25 |
| Carcinogencity | 0.062 |
| EI | 0.023 |
| Respiratory | 0.921 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.596397 |